vs
Side-by-side financial comparison of Net Lease Office Properties (NLOP) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Net Lease Office Properties is the larger business by last-quarter revenue ($30.7M vs $18.3M, roughly 1.7× ROCKWELL MEDICAL, INC.). Net Lease Office Properties runs the higher net margin — -0.2% vs -3.0%, a 2.8% gap on every dollar of revenue. On growth, Net Lease Office Properties posted the faster year-over-year revenue change (10.9% vs -25.6%). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -16.4%).
Net Lease Office Properties is a real estate investment entity focused on acquiring, owning, and operating high-quality single-tenant net lease office assets, primarily located across the United States. It delivers stable, long-term income streams to investors through its curated portfolio of commercial real estate holdings.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NLOP vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.7M | $18.3M |
| Net Profit | $-53.0K | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | -0.2% | -2.2% |
| Net Margin | -0.2% | -3.0% |
| Revenue YoY | 10.9% | -25.6% |
| Net Profit YoY | 99.9% | 26.7% |
| EPS (diluted) | $-0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.7M | $18.3M | ||
| Q3 25 | $29.8M | $15.9M | ||
| Q2 25 | $29.2M | $16.1M | ||
| Q1 25 | $29.2M | $18.9M | ||
| Q4 24 | $27.7M | $24.7M | ||
| Q3 24 | $31.5M | $28.3M | ||
| Q2 24 | $39.0M | $25.8M | ||
| Q1 24 | $44.0M | $22.7M |
| Q4 25 | $-53.0K | $-554.0K | ||
| Q3 25 | $-64.2M | $-1.8M | ||
| Q2 25 | $-81.5M | $-1.5M | ||
| Q1 25 | $492.0K | $-1.5M | ||
| Q4 24 | $-35.8M | $-756.0K | ||
| Q3 24 | $-40.3M | $1.7M | ||
| Q2 24 | $12.5M | $343.0K | ||
| Q1 24 | $-27.8M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | -0.2% | -2.2% | ||
| Q3 25 | -215.2% | -9.9% | ||
| Q2 25 | -279.1% | -8.4% | ||
| Q1 25 | 2.0% | -7.2% | ||
| Q4 24 | -140.7% | -2.1% | ||
| Q3 24 | -126.4% | 6.8% | ||
| Q2 24 | 32.3% | 2.0% | ||
| Q1 24 | -62.7% | -5.8% |
| Q4 25 | -0.2% | -3.0% | ||
| Q3 25 | -215.4% | -11.0% | ||
| Q2 25 | -279.5% | -9.3% | ||
| Q1 25 | 1.7% | -8.0% | ||
| Q4 24 | -129.0% | -3.1% | ||
| Q3 24 | -128.0% | 5.9% | ||
| Q2 24 | 31.9% | 1.3% | ||
| Q1 24 | -63.3% | -7.6% |
| Q4 25 | $-0.01 | $-0.01 | ||
| Q3 25 | $-4.33 | $-0.05 | ||
| Q2 25 | $-5.50 | $-0.05 | ||
| Q1 25 | $0.03 | $-0.04 | ||
| Q4 24 | $-2.41 | $-0.02 | ||
| Q3 24 | $-2.73 | $0.04 | ||
| Q2 24 | $0.84 | $0.01 | ||
| Q1 24 | $-1.88 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $119.6M | $10.7M |
| Total DebtLower is stronger | $21.9M | — |
| Stockholders' EquityBook value | $293.9M | $37.0M |
| Total Assets | $453.4M | $57.1M |
| Debt / EquityLower = less leverage | 0.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $119.6M | $10.7M | ||
| Q3 25 | $38.7M | $13.6M | ||
| Q2 25 | $54.1M | $12.5M | ||
| Q1 25 | $28.2M | $11.4M | ||
| Q4 24 | $25.1M | $15.7M | ||
| Q3 24 | $36.1M | $12.3M | ||
| Q2 24 | $36.1M | $11.9M | ||
| Q1 24 | $39.8M | $6.6M |
| Q4 25 | $21.9M | — | ||
| Q3 25 | $47.1M | — | ||
| Q2 25 | $117.2M | — | ||
| Q1 25 | $148.5M | — | ||
| Q4 24 | $169.2M | — | ||
| Q3 24 | $239.4M | — | ||
| Q2 24 | $327.4M | — | ||
| Q1 24 | $515.2M | — |
| Q4 25 | $293.9M | $37.0M | ||
| Q3 25 | $430.3M | $37.0M | ||
| Q2 25 | $500.0M | $30.4M | ||
| Q1 25 | $582.1M | $31.5M | ||
| Q4 24 | $581.2M | $32.6M | ||
| Q3 24 | $621.9M | $29.1M | ||
| Q2 24 | $660.3M | $23.5M | ||
| Q1 24 | $647.2M | $20.6M |
| Q4 25 | $453.4M | $57.1M | ||
| Q3 25 | $522.6M | $57.5M | ||
| Q2 25 | $668.7M | $52.6M | ||
| Q1 25 | $784.1M | $54.0M | ||
| Q4 24 | $805.1M | $59.2M | ||
| Q3 24 | $919.9M | $57.1M | ||
| Q2 24 | $1.0B | $53.0M | ||
| Q1 24 | $1.2B | $50.7M |
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.11× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.26× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.80× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.1M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.1M | $2.3M | ||
| Q3 25 | $16.3M | $-1.3M | ||
| Q2 25 | $11.7M | $1.8M | ||
| Q1 25 | $14.1M | $-3.5M | ||
| Q4 24 | $71.9M | $865.0K | ||
| Q3 24 | $20.3M | $4.3M | ||
| Q2 24 | $14.7M | $1.4M | ||
| Q1 24 | $26.4M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.70× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 1.18× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NLOP
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
